Latest Jubilant Pharmova News
All-In-One Jubilant Pharmova Stock News Hub: Explore the latest Jubilant Pharmova stock and industry news. Quickly find information on Jubilant Pharmova stock buybacks,Jubilant Pharmova results, Jubilant Pharmova company analysis, Jubilant Pharmova live prices, Jubilant Pharmova dividends, Jubilant Pharmova bonus share, board meetings, lifetime highs, Jubilant Pharmova targets, lows, and growth stories with AI.
CNBC TV18
Jubilant Pharmova clears FDA inspection of Washington facilities
The inspection, which took place from September 18 to 25, covered both the allergy immunotherapy facility and the contract manufacturing facility. Shares of Jubilant Pharmova Ltd ended at ₹1,183.90, down by ₹25.75, or 2.13%, on the BSE.
•
Thu, Sep 26, 2024
Business Standard
Jhunjhunwala Portfolio: This pharma stock has zoomed over 100% in 6 months
Shares of Jubilant Pharmova surged 12 per cent on the BSE in Friday's intra-day trade to hit a new high of Rs 1,169.55, in an otherwise subdued market.
•
Fri, Sep 13, 2024
Business Standard
Jubilant Pharmova hits all time high on receiving 'VAI' tag for US facility
Jubilant Pharmova share price rose as much as 4.2 per cent, touching its all time high at Rs 1060.15 per share on the BSE in early hours of Wednesday's intraday deals
•
Wed, Sep 11, 2024
Business Standard
Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA
Jubilant Pharmova advanced 1.60% to Rs 1,033.55 after its subsidiary, Jubilant HollisterStier LLC's (JHS) manufacturing facility located at Spokane, Washington (USA) received classification of "Voluntary Action Indicated" from USFDA.
•
Wed, Sep 11, 2024
CNBC TV18
Jubilant Pharmova subsidiary gets US FDA note for Washington unit
Following an audit conducted from May 28-June 6, 2024, the US FDA has classified the drug firm's Spokane, Washington, manufacturing facility's inspection status as 'voluntary action indicated' (VAI). Shares of Jubilant Pharmova Ltd ended at ₹1,014.10, down by ₹16.30, or 1.58%, on the BSE.
•
Tue, Sep 10, 2024
Business Standard
Jubilant Pharmova Ltd leads gainers in 'A' group
Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemicals Ltd are among the other gainers in the BSE's 'A' group today, 09 September 2024.
•
Mon, Sep 9, 2024
The Economic Times
How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains
We own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on the US soil and the US government would have the right of first refusal on production on the facility. And when the US government does not want to source material from that facility, the company is free to manufacture other materials and sell it to whoever they wish to sell.
•
Fri, Sep 6, 2024
CNBC TV18
Jubilant Pharmova's subsidiary to acquire 80% stake in Pierre Fabre's R&D centre in France
Shares of Jubilant Pharmova Ltd ended at ₹854.90, down by ₹7.05, or 0.82% on the BSE.
•
Fri, Aug 16, 2024
Mint
Rakesh Jhunjhunwala Stocks: Geojit Financial Services, Raghav Productivity Enhancers Ltd, Jubilant Pharmova , NCC Ltd are the stocks in the Rakesh Jhunjhunwala and Associates Portfolio that have given Multibagger returns during last one year. Check details change in shareholdings.
•
Wed, Aug 14, 2024
The Economic Times
Jubilant Pharmova's US arm prepays Rs 626 crore term loan
Jubilant Pharmova's US subsidiary secured a $75 million term loan, as of March 31, 2024, the company's gross debt stood at Rs. 3,414 crore and net debt at Rs. 2,457 crore. In FY24, the company reported revenue of Rs. 6,772 crore and a net profit of Rs. 195 crore. The net debt to Ebitda ratio improved from 2.93x to 2.48x.
•
Tue, Jun 25, 2024